Events

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM EDT

1 RACE-Approved Credit Hour 
RACE# 27059-906349

Veterinarians and Technicians are invited.

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

12:00 PM EDT

1 RACE-Approved Credit Hour 
 

In this presentation, the primary focus will be on the early diagnosis and treatment of skin and subcutaneous masses. Attendees will be encouraged to overcome any frustration resulting from doing aspirates, non-diagnostic samples, or seemingly untreatable tumors. New guidelines for the timely diagnosis of lumps and bumps in patients will be discussed. The importance of early diagnosis will be emphasized, as the majority of skin and subcutaneous tumors can be successfully cured with surgery alone, so it's important not to wait. Techniques for enhancing cytology proficiency will be explored, and the presentation will include an interactive session where real-life cytology case examples will be examined, enabling attendees to determine the tissue of origin and distinguish between benign and malignant masses. As advocates of the 'Why Wait? Aspirate' cancer awareness program, the aim is to empower attendees to adopt a proactive approach with the motto 'See Something, Do Something'

7 PM EDT

1 RACE-Approved Credit  

RACE# 27059-1267612

Veterinarians and Technicians are invited.

Humanization of pets has us now using terms like furry children as most pet parents consider their dogs, cats, and other companion animals true family members. And as many of these parents are using supplements for themselves, they are eager to purchase pet supplements with specific health benefits for their furry family members. The global pet supplement market size was worth around USD 1.91 billion in 2022 and is predicted to have strong market growth estimated to be USD 3.12 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.91% between 2023 and 2030. Success in this market will require understanding pet humanization, the perspectives of pet parents and veterinarians, and how pet supplements and nutrition differ from humans. As many pet parents are using supplements for themselves, they are eager to purchase pet supplements with specific health benefits for their furry family members. The pet supplement market is rapidly growing yet, we barely understand what these magical ingredients are much less can determine if they are safe or efficacious And most pet parents are using multiple pet supplements and even treats have some of these special ingredients.Is it all fairy dust or is there some science that supports the use of supplements in your practice?

7 PM EST

1 RACE-Approved Credit  

RACE# 27059-1264304

Veterinarians and Technicians are invited.

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM AST

1 RACE-Approved Credit Hour 
RACE# 27059-906349

Veterinarians only, please.

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM PDT
1 RACE-Approved Credit  
RACE# 27059-1093960

One Technician/Practice Manager may accompany a Veterinarian. Please reach out if you have additional registered technicians who would like to attend.

After nearly a decade of FDA-approval of non-nitrogenous bisphosphonates for use in horses, this presentation is meant to review our current understanding of these drugs and introduce newly available scientific data and research. Topics will include clinical efficacy data, pharmacokinetic studies, equine safety studies, and recently discovered effects in non-bone cells. To conclude, there will be an overview of some recent and relevant non-nitrogenous bisphosphonate clinical trials.

Bisphosphates are a unique drug class with new discoveries regularly occurring in both human and veterinary medicine. This presentation will give attendees an opportunity to review previously known information and learn about recent developments in this drug class. This practical knowledge can be applied in the clinical setting when considering the use of bisphosphonate drugs in equine patients. Part 2: The presenter reviews equine osteoarthritis (OA) and chondroprotective therapies. Focus areas include basic anatomy of the joint, articular cartilage composition and function, pathophysiology of OA including histologic progression, and types of chondroprotective therapies. The types of therapies discussed will include Hyaluronate Sodium (HA), Glycosaminoglycan (PSGAG), Pentosan Polysulfate (PPS) and regenerative autologous blood products currently indicated for OA and/or degenerative joint disease in horses. Additionally a meta-analysis of current research with regard to equine OA treatments will be analyzed.

07:00 PM EDT

1 RACE-Approved Credit Hour RACE#s 27059-933819, 1077078

Veterinarians only, please.

The presenter reviews equine osteoarthritis (OA) and chondroprotective therapies. Focus areas include basic anatomy of the joint, articular cartilage composition and function, pathophysiology of OA including histologic progression, and types of chondroprotective therapies. The types of therapies discussed will include Hyaluronate Sodium (HA), Glycosaminoglycan (PSGAG), Pentosan Polysulfate (PPS) and regenerative autologous blood products currently indicated for OA and/or degenerative joint disease in horses. Additionally a meta-analysis of current research with regard to equine OA treatments will be analyzed.

08:00 PM EDT

1 RACE-Approved Credit Hour 
RACE# 27059-1077078

Veterinarians and Technicians are invited.

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

Veterinarians and Technicians are invited.

07:00 PM EDT

RACE# 27059-918761
1 RACE-Approved Credit Hour

This session will discuss utilizing a multifaceted approach to the management of Feline CKD. It will include perfusion/hydration as well as medical management of anemia, hypertension, proteinuria and other symptoms of CKD. The nutritional management of CKD will be discussed as adjunctive therapy. Finally the speaker will discuss individualizing the management plan to the patient and when it becomes time to consider quality of life.

Veterinarians and Technicians are invited.

07:00 PM EDT

RACE# 27059-1266070
1 RACE-Approved Credit Hour

This presentation will educate clinicians on all aspects of hyperadrenocorticism (HAC) diagnosis and treatment. It will include HAC signalment, clinical signs, complications, screening tests, and the specific endocrine testing used to diagnose the condition. In addition, the use of trilostane for disease management and its monitoring and side effects will be discussed. Multiple case studies will also be presented to make the presentation as clinically relevant as possible.

One Technician/Practice Manager may accompany a Veterinarian.

07:30 PM PDT

1 RACE-Approved Credit  

RACE# 27059-1262330

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM MST

1 RACE-Approved Credit Hour 
RACE# 27059-906349

Veterinarians and Technicians are invited.

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7:00 P.M. EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

Veterinarians only, please.

Dermatologist Joya Griffin will walk the attendee through the importance of cytology for diagnosing and treating otitis externa. This will include treating for certain pathogens and tailoring your approach to the individual case of otitis. She will then discuss pitfalls to avoid that lead to treatment failures and finally will help the attendee to formulate a comprehensive treatment plan to minimize recurrence of OE.

Veterinarians and Technicians are invited.

07:00 PM EDT

RACE# 27059-1264320
1 RACE-Approved Credit Hour

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

3:00 PM EDT

1 RACE-Approved Credit Hour 
 

The presenter will discuss different types of fluids available for use in veterinary patients with a short review of the types, the differences between the types, and a brief description on the use of crystalloids vs colloids. The presenter will also touch on appropriate fluid therapy types, techniques, and rates for resuscitation, rehydration, and preventing continuing fluid loss. The presentation will be from a criticalists perspective but will be geared to general practice.

Veterinarians and Technicians are invited.

07:00 PM EDT

RACE# 27059-1201360
1 RACE-Approved Credit Hour

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM MDT

1 RACE-Approved Credit Hour 
RACE# 27059-906349

Veterinarians and Registered Technicians only, please.

The presenter will discuss the general principles for fluid therapy in equine critical care cases. Topics will include types of fluids, rate and volume of administration, goals and end points, and safety limits. Additionally, the physiologic parameters of fluid compartments will be assessed including total body water, extracellular fluid, and intracellular fluid.

Veterinarians and Technicians are invited.

08:30 PM EDT

RACE# 27059-1261231
1 RACE-Approved Credit Hour

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

12:00 PM EDT

1 RACE-Approved Credit Hour 
 

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM EDT

1 RACE-Approved Credit Hour 
RACE# 27059-906349

Veterinarians and Technicians are invited.

This presentation will educate clinicians on all aspects of hyperadrenocorticism (HAC) diagnosis and treatment. It will include HAC signalment, clinical signs, complications, screening tests, and the specific endocrine testing used to diagnose the condition. In addition, the use of trilostane for disease management and its monitoring and side effects will be discussed. Multiple case studies will also be presented to make the presentation as clinically relevant as possible.

07:00 PM EDT

1 RACE-Approved Credit Hour 
RACE# 27059-1262330

Veterinarians and Technicians are invited.

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

Veterinarians and Technicians are invited.

07:00 PM EDT

RACE# 27059-918761
1 RACE-Approved Credit Hour

The presenter will discuss Canine Hypoadrenocorticism with a case based approach. There will be a review of common clinical signs, case examples, and treatment of the disease.

Veterinarians and Technicians are invited.

07:00 PM EDT

RACE# 27059-1120400
1 RACE-Approved Credit Hour